BSE - Delayed Quote INR

Entero Healthcare Solutions Limited (ENTERO.BO)

1,196.35
-0.40
(-0.03%)
At close: June 13 at 3:28:01 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
50,957,800
50,957,800
39,223,100
32,931,430
25,152,670
Cost of Revenue
46,094,740
46,094,740
35,703,530
30,318,650
23,124,370
Gross Profit
4,863,060
4,863,060
3,519,570
2,612,780
2,028,300
Operating Expense
3,454,500
3,454,500
2,651,310
2,161,290
1,918,960
Operating Income
1,408,560
1,408,560
868,260
451,490
109,340
Net Non Operating Interest Income Expense
-416,220
-416,220
-656,840
-448,820
-255,390
Pretax Income
1,387,390
1,387,390
355,550
-36,880
-198,110
Tax Provision
313,050
313,050
-42,440
74,160
96,280
Net Income Common Stockholders
948,200
948,200
391,090
-115,570
-299,200
Diluted NI Available to Com Stockholders
948,200
948,200
391,090
-115,570
-299,200
Basic EPS
20.72
21.80
10.81
-2.66
-6.88
Diluted EPS
20.72
21.76
10.81
-2.66
-6.88
Basic Average Shares
43,493.77
43,495.41
36,178.54
43,498.97
43,498.97
Diluted Average Shares
43,493.77
43,575.37
36,178.54
43,498.97
43,498.97
Rent Expense Supplemental
--
--
6,740
16,650
14,730
Total Expenses
49,549,240
49,549,240
38,354,840
32,479,940
25,043,330
Net Income from Continuing & Discontinued Operation
948,200
948,200
391,090
-115,570
-299,200
Normalized Income
948,200
948,200
391,090
-77,917
-255,450
Interest Income
--
--
133,320
40,900
34,390
Interest Expense
416,220
416,220
656,840
444,000
260,950
Net Interest Income
-416,220
-416,220
-656,840
-448,820
-255,390
EBIT
1,803,610
1,803,610
1,012,390
407,120
62,840
EBITDA
2,110,530
2,110,530
1,262,560
649,490
260,380
Reconciled Cost of Revenue
46,094,740
46,094,740
35,703,530
30,318,650
23,124,370
Reconciled Depreciation
306,920
306,920
250,170
242,370
197,540
Net Income from Continuing Operation Net Minority Interest
948,200
948,200
391,090
-115,570
-299,200
Total Unusual Items Excluding Goodwill
--
--
-74,810
-53,790
-62,500
Total Unusual Items
--
--
-74,810
-53,790
-62,500
Normalized EBITDA
2,110,530
2,110,530
1,262,560
703,280
322,880
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-16,137
-18,750
3/31/2022 - 2/16/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade